Q2 Holdings, Inc. to Attend Upcoming Conferences During Third Quarter 2023
AUSTIN, Texas–(BUSINESS WIRE)–Q2 Holdings, Inc. (NYSE: QTWO), a leading provider of digital banking and lending…
Year: 2023
Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock
BOSTON, July 27, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare…
Tonix Pharmaceuticals Announces Pricing of $7 Million Public Offering
CHATHAM, N.J., July 27, 2023 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix”…
McAllen Truck Accident Injury Attorney Services Announced By Reyna Law Firm
South Texas personal injury lawyers Reyna Law Firm have announced their damage claim representation services…
Liberty Latin America Schedules Investor Call for Second Quarter 2023 Results
DENVER, Colorado–(BUSINESS WIRE)–Liberty Latin America Ltd. (“Liberty Latin America” or the “Company”) (NASDAQ: LILA and…
COPT Reports Second Quarter 2023 Results
EPS of $0.27 for 2Q23; FFO per Share, as Adjusted for Comparability, of $0.60 Exceeded…
Pioneer Natural Resources Releases 2023 Sustainability Report
DALLAS–(BUSINESS WIRE)–Pioneer Natural Resources Company (NYSE: PXD) (“Pioneer” or “the Company”) today announced the publication…
World Kinect Corporation Reports Second Quarter 2023 Results
Second Quarter 2023 Highlights Gross profit increased 11% to $282 million Net income increased 23%…
Juniper Networks Reports Preliminary Second Quarter 2023 Financial Results
SUNNYVALE, Calif.–(BUSINESS WIRE)–Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today reported preliminary…
Global Citeline Awards Recognize TrialWire™ Rapid Patient Recruitment Platform as “Best Patient-facing Technology Initiative 2023”
BOSTON, July 27, 2023 (GLOBE NEWSWIRE) — TrialWire™ Rapid Patient Recruitment Platform, the pay per…
Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET
HOLLISTON, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce…
Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients
BARCELONA, Jul 28, 2023 – (ACN Newswire) – Peptomyc S.L., a biotech company specialized in…
Houlihan Lokey Reports First Quarter Fiscal 2024 Financial Results
– First Quarter Fiscal 2024 Revenues of $416 million – – First Quarter Fiscal 2024…
Principal Financial Group® Announces Second Quarter 2023 Results
Declares increase to third quarter 2023 common stock dividend Company Highlights Second quarter 2023 net…
Redwood Trust Reports Second Quarter 2023 Financial Results
MILL VALLEY, Calif.–(BUSINESS WIRE)–Redwood Trust, Inc. (NYSE:RWT; “Redwood” or the “Company”), a leader in expanding…
LTC Reports 2023 Second Quarter Results and Discusses Recent Activities
WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC Properties, Inc. (NYSE: LTC) (“LTC” or the “Company”), a real estate…
Genmab Updates 2023 Financial Guidance
Company Announcement COPENHAGEN, Denmark; July 28, 2023 – Genmab A/S (Nasdaq: GMAB) announced today its…
Belite Bio Doses First Subject in Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant for GA
Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended to slow disease progression in…
SIGA Announces U.S. Government Procurement Orders of Approximately $138 Million for Oral and IV TPOXX®
Exercise of Procurement Options of Approximately $113 Million for Oral TPOXX and Approximately $25 Million…
Correction: Inventiva Reports Preliminary 2023 First-Half Financial Information¹ and Business update
Cash and cash equivalents at €31.2 million, short-term deposits at €0.05 million2, and long-term deposit…